Unlock stock picks and a broker-level newsfeed that powers Wall Street.
6.66
-0.45
(-6.40%)
At close: 4:00:00 PM EDT
6.65
-0.01
(-0.08%)
After hours: 4:12:04 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 18 | 26 | 23 |
| Avg. Estimate | -1.26 | -1.15 | -4.78 | -4.51 |
| Low Estimate | -1.4 | -1.39 | -5.71 | -6.1 |
| High Estimate | -0.89 | -0.85 | -3.19 | -1.34 |
| Year Ago EPS | -1.12 | -1.52 | -5.25 | -4.78 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 20 | 20 | 28 | 26 |
| Avg. Estimate | 11.39M | 11.37M | 47.51M | 41.94M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 50M | 50M | 210M | 100M |
| Year Ago Sales | 28.93M | 6.96M | 57.88M | 47.51M |
| Sales Growth (year/est) | -60.65% | 63.41% | -17.91% | -11.73% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.36 | -1.2 | -1.37 | -1.32 |
| EPS Actual | -1.12 | -1.52 | -1.34 | -1.27 |
| Difference | 0.24 | -0.32 | 0.03 | 0.05 |
| Surprise % | 17.66% | -27.02% | 2.13% | 3.52% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.26 | -1.15 | -4.78 | -4.51 |
| 7 Days Ago | -1.26 | -1.15 | -4.78 | -4.56 |
| 30 Days Ago | -1.36 | -1.28 | -5.14 | -4.76 |
| 60 Days Ago | -1.37 | -1.31 | -5.15 | -4.98 |
| 90 Days Ago | -1.38 | -1.4 | -5.47 | -5.41 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 1 | -- |
| Up Last 30 Days | 8 | 10 | 18 | 8 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 2 | 1 | 3 | 3 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NTLA | -12.85% | 24.23% | 8.93% | 5.68% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | HC Wainwright & Co.: Buy | 3/5/2025 |
| Maintains | Truist Securities: Buy to Buy | 3/4/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/28/2025 |
| Maintains | Citigroup: Neutral to Neutral | 2/28/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Maintains | Chardan Capital: Buy to Buy | 2/28/2025 |
Related Tickers
BEAM Beam Therapeutics Inc.
17.64
-9.70%
CRSP CRISPR Therapeutics AG
33.14
-2.62%
EDIT Editas Medicine, Inc.
1.1300
-2.59%
CRBU Caribou Biosciences, Inc.
0.8411
-7.89%
VERV Verve Therapeutics, Inc.
4.1350
-9.52%
PRME Prime Medicine, Inc.
1.7850
-10.30%
BLUE bluebird bio, Inc.
5.25
+7.58%
IOVA Iovance Biotherapeutics, Inc.
3.2500
-2.40%
RXRX Recursion Pharmaceuticals, Inc.
5.10
-3.69%
SRPT Sarepta Therapeutics, Inc.
61.91
-2.99%